| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10041806 | HBV | ENSG00000115170.16 | protein_coding | ACVR1 | Yes | No | 90 | D3DPA4 Q04771 |
| TVIS30051531 | HIV | ENSG00000115170.16 | protein_coding | ACVR1 | Yes | No | 90 | D3DPA4 Q04771 |
| TVIS20017824 | HPV | ENSG00000115170.16 | protein_coding | ACVR1 | Yes | No | 90 | D3DPA4 Q04771 |
| TVIS20055584 | HPV | ENSG00000115170.16 | protein_coding | ACVR1 | Yes | No | 90 | D3DPA4 Q04771 |
| TVIS44044465 | HTLV-1 | ENSG00000115170.16 | protein_coding | ACVR1 | Yes | No | 90 | D3DPA4 Q04771 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | ACVR1 |
|---|---|
| DrugBank ID | DB11763 |
| Drug Name | Momelotinib |
| Target ID | BE0000264 |
| UniProt ID | Q04771 |
| Regulation Type | inhibitor |
| PubMed IDs | 31450973 |
| Citations | Xu L, Feng J, Gao G, Tang H: Momelotinib for the treatment of myelofibrosis. Expert Opin Pharmacother. 2019 Nov;20(16):1943-1951. doi: 10.1080/14656566.2019.1657093. Epub 2019 Aug 26. |
| Groups | Approved; Investigational |
| Direct Classification | Phenylpyrimidines |
| SMILES | O=C(NCC#N)C1=CC=C(C=C1)C1=CC=NC(NC2=CC=C(C=C2)N2CCOCC2)=N1 |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL1078178 |
